Virpax Pharmaceuticals, Inc. (VRPX)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 2.1600 |
| Open | 2.2000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 2.2000 - 2.4915 |
| 52 Week Range | 2.1050 - 11.7700 |
| Volume | |
| Avg. Volume | 25,731 |
| Market Cap | 2.764M |
| Beta (5Y Monthly) | 1.56 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
BERWYN, Pa., April 30, 2024--Virpax Announces Results of MTD Study for Probudur. Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief
- Business Wire
Virpax Pharmaceuticals Reports 2023 Year-End Results
BERWYN, Pa., March 26, 2024--Virpax Reports 2023 Year-End Results
- Business Wire
Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
© 2024 Yahoo. All rights reserved.